Skip to content
Erudio Health
menu
Clinical trial · no report yet · Phase 2/Phase 3

VA STARPORT

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

  • NCT04787744 ↗
  • Active, not recruiting
  • VA Office of Research and Development
  • Focused

We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.

Preliminary discovery

Commentary in our index that names this trial so far

Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.

ChannelFound
X threads10

The trial

ClinicalTrials.gov
Official title
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for OligoRecurrenT Prostate Cancer (VA STARPORT)
Phase
Phase 2/Phase 3
Status
Active, not recruiting
Conditions
Prostate Cancer; Oligometastasis; Oligorecurrence; Recurrent Prostate Cancer; Metastatic Prostate Cancer; De Novo Prostate Cancer
Interventions
PET-directed Local Therapy using Surgery; PET-directed Local Therapy using Radiation; Salvage Local Therapy for locally recurrent disease; Goserelin, Histrelin, Leuprolide & Triptorelin; ADT + Nilutamide, Flutamide, & Bicalutamide; Degarelix & Relugolix; ADT + Docetaxel +/- prednisone; ADT + Abiraterone + Prednisone; ADT + Abiraterone + Methylprednisolone; ADT + Apalutamide; ADT + Enzalutamide; Prostate-directed Radiation for De novo oligometastatic prostate cancer
Arms
  • Standard Systemic Therapy (SST) · Active comparator
  • SST + PET-directed local therapy · Experimental
Enrollment
378
Primary outcomes
  • Castration-resistant prostate cancer-free survival (CRPC-free survival)
Sponsor
VA Office of Research and Development
Start
Jul 1, 2021
Primary completion
Oct 2, 2026
Results posted
No
Registry record
NCT04787744 · updated Oct 19, 2026